Alcon hires new VP, CFO

Karsunky most recently served as CFO in the Consumer Health Division of Novartis, where he took up the responsibilities of the division’s finance, information technologies, procurement and merger and acquisition activities.

Before joining Novartis, Karsunky served for four years as the VP of Finance for the international division of Medtronic.

Karsunky began his career with Eli Lilly in 1991 where he had a variety of increasingly responsible financial positions to become the executive director of Finance for Intercontinental and Japan from 2000 to 2002.

Alcon CEO Kevin Buehler said that Karsunky’s broad experience in finance and leadership roles with three health care companies will be a tremendous asset to Alcon as they execute their growth strategies.

“Furthermore, his knowledge of the Novartis organisation will be beneficial in optimising the opportunities to create value for Alcon through cooperative efforts and arm’s length agreements with our new majority shareholder,” Buehler said.

Alcon manufactures, researches, develops and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye.